HER2/Neu Positive Recruiting Phase 1 Trials for 9CUAB30 (DB12316)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02876640Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast CancerPrevention